Found 62 matching trials
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis PHASE3 To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i....
Show More Status
Active Not Recruiting
Location
UAB Childrens Hospital Harbor Center Neurology Dept
Learn More & Join Trial
Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis PHASE4 This study is to find out if there is any benefit to adding Simvastatin to ...
Show More Location
Coordinating Research Site
Learn More & Join Trial
Avonex (Interferon-beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-remitting MS PHASE4 The primary objective of this study is to determine whether combination tre...
Show More Location
CUB Hôpital Erasme
Learn More & Join Trial
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) PHASE3 The purpose of this study is to determine whether ozanimod is effective in ...
Show More Learn More & Join Trial
Effect of Adrenocorticotropin Injection With Weekly Interferon Beta in Patients With Relapsing Remitting Multiple Sclerosis (MS) PHASE2 The purpose of this study is to evaluate whether the use of ACTH in additio...
Show More Location
University at Buffalo, Buffalo General Hospital
Learn More & Join Trial
A Study to Evaluate Rebif® New Formulation (Interferon-beta-1a) in Relapsing Remitting Multiple Sclerosis PHASE3 General Note: throughout this record, "Rebif® New Formulation" is used for ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) or Glatiramer Acetate in Relapsing Multiple Sclerosis (RMS) PHASE2 The primary objectives of the study are to evaluate the safety of BIIB061 v...
Show More Location
Multiple Locations
Learn More & Join Trial
Early Interferon-beta Treatment for West-Nile Virus Infection PHASE2 West Nile virus (WNV) is a mosquito-borne virus which in majority of cases ...
Show More Location
Tel-Aviv Sourasky Medical Center
Learn More & Join Trial
A Multicentre Study of the Efficacy and Safety of Supplementary Treatment With Cholecalciferol in Patients With Relapsing Multiple Sclerosis Treated With Subcutaneous Interferon Beta-1a 44 µg 3 Times Weekly PHASE2 The aim of this multicentre, randomised, double-blind, placebo-controlled s...
Show More Location
CHU Hôpital Gui de Chauliac Service de Neurologie B
Learn More & Join Trial
Study of Evobrutinib in Participants With Relapsing Multiple Sclerosis (RMS) PHASE3 The study was to evaluate the efficacy and safety of evobrutinib administer...
Show More Location
Please Contact U.S. Medical Information
Learn More & Join Trial